| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/25/2012 | CN102327279A Triptolide and lonicerin compatible medicine composition, preparation and application thereof |
| 01/25/2012 | CN102327276A Injecta for treating bacterial encephalitis of dog and preparation method thereof |
| 01/25/2012 | CN102327274A Adrenal cortical hormone compound preparation |
| 01/25/2012 | CN102327273A Compound clobetasol propionate nano-medicament and preparation method thereof |
| 01/25/2012 | CN102327267A Pharmaceutical compositions |
| 01/25/2012 | CN102327227A Preparation method of polyethylene glycol-poly(gamma-amino-epsilon-caprolactone) nano particle loaded with glycyrrhetic acid |
| 01/25/2012 | CN102327216A Limaprost nanoemulsion preparation for vertebral canal injection of antisternum |
| 01/25/2012 | CN102327213A Triamcinolone acetonaide acetate nano eye drops and preparation method thereof |
| 01/25/2012 | CN102327212A Triamcinolone acetonaide acetate nano controlled-release formulation, preparation method thereof and artificial lens containing same |
| 01/25/2012 | CN102327211A Pharmaceutical manufacturing process for heat sterilized glucocorticoid suspensions |
| 01/25/2012 | CN102091006B Tea extract facial cleanser and preparation method thereof |
| 01/25/2012 | CN101972453B Chinese medicinal liquor for treating rheumatic and rheumatoid arthritis and preparation method thereof |
| 01/25/2012 | CN101954045B Traditional Chinese medicinal composition for treating damp arthralgia and preparation method thereof |
| 01/25/2012 | CN101953918B Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases |
| 01/25/2012 | CN101940618B Drug combination with antiinflammatory action and abirritation and preparation method and application thereof |
| 01/25/2012 | CN101904884B Quality detection method for Chinese medicinal compound isatis root granules |
| 01/25/2012 | CN101897838B External hot applied mud moxibustion for human body and application method thereof |
| 01/25/2012 | CN101856425B Externally applied medicine for alleviating cancer pain and preparation method thereof |
| 01/25/2012 | CN101804158B Paste for traumatic injuries |
| 01/25/2012 | CN101732279B Aspirin enteric coated tablet with low content of free salicylic acid and preparation process thereof |
| 01/25/2012 | CN101703576B Medicinal composition for quickening blood, freeing network vessels, soothing the sinews and relieving pain and preparation method thereof |
| 01/25/2012 | CN101703484B Preparation method of hexadecadrol sodium phosphate freeze-dried powder injection |
| 01/25/2012 | CN101642522B Traditional Chinese medicine composition and preparation method thereof |
| 01/25/2012 | CN101632737B Medicament for relieving pain of human body and preparation method thereof |
| 01/25/2012 | CN101606981B Method for extracting component with activities of microbiological resistance and anti-inflammatory from nelumbo nucifer (nulumbo lutea) plant |
| 01/25/2012 | CN101569738B Plaster for treating mastitis, hyperplasia of mammary glands, breast lumps, hydrarthrosis, traumatic injury, preparation method and application thereof |
| 01/25/2012 | CN101255197B Fusion protein for serum albumin and interleukin 1 receptor antagonist and uses thereof |
| 01/25/2012 | CN101167811B External-applied preparation with anti-inflammation, itching-relieving and sterilization function and manufacturing method and application thereof |
| 01/25/2012 | CN101119995B Non steroidal glucocorticoid receptor modulators |
| 01/24/2012 | USRE43140 Immunoregulator |
| 01/24/2012 | US8101793 Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities |
| 01/24/2012 | US8101650 Method for treating a immunology-related disease |
| 01/24/2012 | US8101649 N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors |
| 01/24/2012 | US8101612 N-3-isoxazolyl-4-methyl-3-(1-((1-methylethyl)oxy)-6-phthalazinyl)benzamide; p38 kinase inhibitor; antiinflammatory, analgesic agent; rheumatoid arthritis, osteoporosis, leukemia, psoriasis, Crohn's disease, rhinitis, ulcerative colitis, dermatitis, asthma, Alzheimer's disease, type I and II diabetes |
| 01/24/2012 | US8101381 Human cytokine receptor |
| 01/24/2012 | US8101363 Obtaining a level of a marker of systemic inflammation in individual, comparing level of marker to a predetermined value specific for diagnosis of diabetes or diabetic complications, and characterizing the individual's risk profile |
| 01/24/2012 | US8101211 Controlling moisture, elasticity of skin; using plant extracts; antiinflammatory agents; antiallergens |
| 01/24/2012 | US8101209 Absorption in upper part oof digestive system; oral administering |
| 01/24/2012 | CA2642211C 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases |
| 01/24/2012 | CA2509088C Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 01/24/2012 | CA2498559C Indole derivatives or benzimidazole derivatives for modulating i.kappa.b kinase |
| 01/24/2012 | CA2494761C Oral pharmaceutical compositions comprising cyclosporin |
| 01/24/2012 | CA2493644C Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 01/24/2012 | CA2470230C Pharmaceutical formulation comprising cyclosporin and use thereof |
| 01/24/2012 | CA2459577C An enantiomerically pure opioid diarylmethylpiperazine and methods of using same |
| 01/24/2012 | CA2455227C Use of biologically active hiv-1 tat, fragments or derivates thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 01/24/2012 | CA2439838C (2-hydroxy)ethyl-thioureas useful as modulators of alpha2b adrenergic receptors |
| 01/24/2012 | CA2435687C Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 01/24/2012 | CA2431196C Black tea extract for prevention of disease |
| 01/24/2012 | CA2402092C 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 01/24/2012 | CA2383174C Method of treating cardio pulmonary diseases with no group compounds |
| 01/24/2012 | CA2370763C Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 01/24/2012 | CA2332370C Methods and means for preventing or treating inflammation or pruritis |
| 01/24/2012 | CA2274987C Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily |
| 01/24/2012 | CA2221318C High affinity oligonucleotide ligands to growth factors |
| 01/20/2012 | CA2735631A1 Curcumin formulations and methods for making such formulations |
| 01/19/2012 | WO2012009707A2 Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
| 01/19/2012 | WO2012009611A2 Methods and compositions for cancer immunotherapy |
| 01/19/2012 | WO2012008984A1 (+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof |
| 01/19/2012 | WO2012008549A1 Heterocyclic ring compound |
| 01/19/2012 | WO2012008435A1 Biaryl amide derivative or pharmaceutically acceptable salt thereof |
| 01/19/2012 | WO2012007883A1 Sulfonamide derivatives as nav1.7 inhibitors for the treatment of pain |
| 01/19/2012 | WO2012007375A1 Pyrazolo [1, 5a] pyrimidine and thieno [3, 2b] pyrimidine derivatives as irak4 modulators |
| 01/19/2012 | WO2012006864A1 Triterpenoid saponin compounds, preparation methods and uses thereof |
| 01/19/2012 | WO2011112873A3 Extracorporeal immunoadsorption treatment |
| 01/19/2012 | WO2011112850A3 Humanized and chimeric anti-properdin antibodies |
| 01/19/2012 | WO2011112766A3 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 01/19/2012 | WO2011112687A3 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 01/19/2012 | WO2011098762A3 Antibodies against cxcr4 |
| 01/19/2012 | US20120016467 Polymer-based, sustained release drug delivery system |
| 01/19/2012 | US20120016038 Compositions and methods for altering the rate of hydrolysis of cured oil-based materials |
| 01/19/2012 | US20120016034 Polymorphic Form Of N-(S)-(3,4-Difluoro-2-(2-Fluoro-4-Iodophenylamino)-6-Methoxyphenyl)-1-(2,3-Dihydroxypropyl)Cyclopropane-1-Sulfonamide And Uses Thereof |
| 01/19/2012 | US20120016029 Antagonists of prostaglandin d2 receptors |
| 01/19/2012 | US20120016016 Methods and compositions for treating complications of diabetes and vascular diseases using flavones |
| 01/19/2012 | US20120016002 Patient Selection and Therapeutic Methods Using Markers of Prostaglandin Metabolism |
| 01/19/2012 | US20120015998 Phototherapy methods and devices comprising emissive aryl-heteroaryl compounds |
| 01/19/2012 | US20120015992 Napthalene-Based Inhibitors of Anti-Apoptotic Proteins |
| 01/19/2012 | US20120015991 Polycyclic antagonists of lysophosphatidic acid receptors |
| 01/19/2012 | US20120015985 Methods of Administering Pirfenidone Therapy |
| 01/19/2012 | US20120015983 Synthesis and Novel Salt Forms of (R)-3-((E)-pyrrolidin-3-yl)vinyl)-5-tetrahydropyran-4-yloxy)pyridine |
| 01/19/2012 | US20120015979 Compounds for Modulating TRPV3 Function |
| 01/19/2012 | US20120015977 Quinolinone derivatives useful for the treatment of cns disorders |
| 01/19/2012 | US20120015971 Ophthalmic composition comprising ascomycin |
| 01/19/2012 | US20120015970 New azacyclic compounds |
| 01/19/2012 | US20120015966 Ppar active compounds |
| 01/19/2012 | US20120015963 NOVEL PYRAZOLO[3,4-d]PYRIMIDINE COMPOUNDS |
| 01/19/2012 | US20120015954 Therapeutic agents useful for treating pain |
| 01/19/2012 | US20120015952 Inhibitors of NF-KB |
| 01/19/2012 | US20120015944 Tetrazole-substituted arylamides as p2x3 and p2x2/3 antagonists |
| 01/19/2012 | US20120015939 Topical treatment of neuropathic pain and methods of diagnosis |
| 01/19/2012 | US20120015937 Kinase Inhibitors And Their Uses |
| 01/19/2012 | US20120015933 Spirocyclic nitriles as protease inhibitors |
| 01/19/2012 | US20120015932 Pyrazole Derivatives Used as CCR4 Receptor Antagonists |
| 01/19/2012 | US20120015931 Purine compounds selective for pi3k p110 delta, and methods of use |
| 01/19/2012 | US20120015930 Substituted imidazoheterocycle derivatives |
| 01/19/2012 | US20120015929 Novel compounds as cannabinoid receptor ligands |
| 01/19/2012 | US20120015928 Amido Compounds And Their Use As Pharmaceuticals |
| 01/19/2012 | US20120015923 Use of andrographolide compounds for treating inflammation and airway disorders |
| 01/19/2012 | US20120015920 Heterobicyclic metalloprotease inhibitors |
| 01/19/2012 | US20120015912 Use of 2,5-dihydroxybenzene for the treatment of ocular diseases |